fluorescein has been researched along with su 11248 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Obata, R; Takahashi, H; Tamaki, Y | 1 |
1 other study(ies) available for fluorescein and su 11248
Article | Year |
---|---|
A novel vascular endothelial growth factor receptor 2 inhibitor, SU11248, suppresses choroidal neovascularization in vivo.
Topics: Administration, Oral; Angiogenesis Inhibitors; Animals; Capillary Permeability; Choroidal Neovascularization; Disease Models, Animal; Disease Progression; Female; Fluorescein; Fluorescein Angiography; Indoles; Mice; Mice, Inbred C57BL; Pyrroles; Sunitinib; Vascular Endothelial Growth Factor Receptor-2 | 2006 |